Detailed answers about I-PHARM CONSULTING INTERNATIONAL LIMITED, including incorporation, status, business activity, and accounts information.
When was I-PHARM CONSULTING INTERNATIONAL LIMITED founded?
I-PHARM CONSULTING INTERNATIONAL LIMITED was officially incorporated on 5 February 2013 and is registered under company number 08389470. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is I-PHARM CONSULTING INTERNATIONAL LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of I-PHARM CONSULTING INTERNATIONAL LIMITED?
I-PHARM CONSULTING INTERNATIONAL LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does I-PHARM CONSULTING INTERNATIONAL LIMITED do?
I-PHARM CONSULTING INTERNATIONAL LIMITED operates in the following sectors: 64209 - Activities of other holding companies n.e.c., 74990 - Non-trading company. These SIC codes provide insight into the company's business activities and industry focus.
What is I-PHARM CONSULTING INTERNATIONAL LIMITED's registered address?
The registered office address of I-PHARM CONSULTING INTERNATIONAL LIMITED is MOOR PLACE 1 FORE STREET AVENUE, FORE STREET AVENUE, LONDON, UNITED KINGDOM, EC2Y 9DT. This is the official address filed with Companies House for legal and statutory correspondence.
Is I-PHARM CONSULTING INTERNATIONAL LIMITED financially stable?
The most recent accounts for I-PHARM CONSULTING INTERNATIONAL LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.